(4aS,7R)-1,4a-dimethyl-7-prop-1-en-2-yl-3,4,5,6,7,8-hexahydronaphthalen-2-one | CAS:473-08-5

We serve (4aS,7R)-1,4a-dimethyl-7-prop-1-en-2-yl-3,4,5,6,7,8-hexahydronaphthalen-2-one CAS:473-08-5 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
(4aS,7R)-1,4a-dimethyl-7-prop-1-en-2-yl-3,4,5,6,7,8-hexahydronaphthalen-2-one

Synonyms:
Eudesma-4,11-dien-3-one
Eudesma-4,11-dien-3-on
Alpha-Cyperone
 
Molecular Formula: C15H22O
Molecular weight:218.33500
 
Density: 0.97g/cm3
Boiling point: 320.4ºC at 760mmHg
Flash point: 142.8ºC
Refractive index: 1.503
Vapor Pressure: 0.000319mmHg at 25°C

Uses: Alpha-cyperone is associated with the down-regulation of Cox-2, IL-6, Nck-2, Cdc42, Rac1, thereby reducing inflammatory responses.

Items of Analysis Standard of Analysis Test Results
Appearance Light yellow liquid Conform
Assay ≥98.0% 98.57%
Conclusion Conforms to Factory Standard
Storage 2-8℃, keep package airproof when not in use.
 



Contact us for information like (4aS,7R)-1,4a-dimethyl-7-prop-1-en-2-yl-3,4,5,6,7,8-hexahydronaphthalen-2-one chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Alpha-Cyperone physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Alpha-Cyperone Use and application,Eudesma-4,11-dien-3-on technical grade,usp/ep/jp grade.


Related News: Both patients were being treated in isolation units at a Manila hospital.methyl 4-(2-{1-benzhydryl-5-chloro-2-[2-({[2-(1H-pyrazol-1-yl)ethyl]sulfonyl}amino)ethyl]-1H-indol-3-yl}ethoxy)benzoate manufacturer International Chemical Investors Group (ICIG) recently announced it has entered into a purchase agreement under which an affiliate of ICIG will acquire the pharmaceutical intermediates business from Genzyme Corporation. 4-bromo-3-methyl-5-(3-methyl-ureido)-[1,2,3]oxadiazolium betaine supplier International Chemical Investors Group (ICIG) recently announced it has entered into a purchase agreement under which an affiliate of ICIG will acquire the pharmaceutical intermediates business from Genzyme Corporation. 5-(Methoxycarbonyl)-2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3-carboxylic acid vendor The mode of cooperation between domestic API companies and large international companies can lower the export threshold.The technology supports breakthroughs in medical research and is widely used by major global pharmaceutical companies to advance drug discovery & development and provide data to support regulatory submissions.